HMD

HERAMED FPO [HMD]
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women's health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Hawthorn East, Australia.
Healthcare · ASX Small Cap
$0.0370 -2.6%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when HMD triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track HMD — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • MACD momentum is losing steam
  • Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
  • Critical cash runway (1.5 quarters)
  • Very high P/S ratio (102.0x)
  • Small-cap ($20-100M)
  • Sentiment is mixed — no strong consensus either way
  • The bigger volume days are the up days — volume-weighted momentum is positive (0.99%/day)
  • Altman Z-Score distress zone (1.57 < 1.81, low-confidence approx)
  • Low-priced stock risk ($0.038)
  • RBA hiking (-3pts)
  • Calendar: Quarterly Activities in 9d (+3pts)

Risk Signals

  • Death cross triggered — the short-term trend just crossed below the long-term, which is a bearish signal
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Long-term momentum is negative — down 30% over the past year
Ask Scout AI about HMD
"What's driving HMD today?" "How does HMD compare to peers?" "Key risks for HMD?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE HeraMED successfully completes Phase 1 pilot with Lee Health
NONE Notification of cessation of securities - HMD
NONE Change of Director's Interest Notice - AG
Announcement tone +5pts

Recent ASX Announcements

2026-07-13 HeraMED successfully completes Phase 1 pilot with Lee Health PRICE SENSITIVE
2026-07-03 Notification of cessation of securities - HMD
2026-07-03 Change of Director's Interest Notice - AG
2026-06-24 Notification regarding unquoted securities - HMD
2026-06-24 Notification regarding unquoted securities - HMD

Key Metrics

$44.0M
Market Cap
627K
Avg Volume
1.2x
Vol Ratio
$0.01 — $0.06
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-223.2%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 68%
LLeader vs LaggardlaggardRS: -12
IInstitutional SponsorshipweakInst: 3%
MMarket DirectionneutralNeutral

Sector: Healthcare

101 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
IDT +28.1%ADR +27.3%LDX +23.8%EYE +17.4%ECS -16.7%
Compare:HMD vs IDTHMD vs ADRHMD vs LDX
Scout Pro — Deeper Analysis for HMD
Try Pro free for 30 days
Share this analysis

Track HMD and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required